| Meadow Woods Nursing And Rehab Center | |
| 42235 County Road 390, Bloomingdale, Michigan 49026 | |
| (269) 521-3383 | |
| Name | Meadow Woods Nursing And Rehab Center |
|---|---|
| Location | 42235 County Road 390, Bloomingdale, Michigan |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 67 |
| Occupancy Rate | 65.07% |
| Medicare ID (CCN) | 235640 |
| Legal Business Name | Bloomingdale Care Operating Co Llc |
| Ownership Type | For Profit - Limited Liability Company |
| NPI Number | 1245242676 |
| Organization Name | BETHANY CARE CENTER L.L.C |
| Doing Business As | METRON OF BLOOMINGDALE |
| Address | 42235 County Road 390, Bloomingdale, MI 49026 |
| Phone Number | 269-521-3383 |
News Archive
Uganda "has overcome a violent past, but hope is daily threatened by a force more deadly than any warlord or civil unrest": the mosquito, Ugandan Health Minister Christine Ondoa writes in a GlobalPost opinion piece. According to the WHO, "Uganda has the highest incidence of malaria in the world," and the disease is endemic in more than 95 percent of the country, she notes.
A new study from University of Manchester researchers, published in ACS Neuro, shows a high possibility of treating stroke patients using very small cell sacs called liposomes to bypass the blood brain barrier and carry lifesaving drugs to the brain to prevent damage following a stroke.
Inspire Pharmaceuticals, Inc. announced today that it has been communicating with the U.S. Food and Drug Administration (FDA) and is increasing its production of AzaSite® (azithromycin ophthalmic solution) 1% in response to the manufacturing supply shortage of erythromycin ophthalmic ointment (0.5%).
"For the first time, with support from the GAVI Alliance, a pentavalent vaccine was introduced in Myanmar this week that will defend children against five potentially fatal diseases," Dagfinn Hoybraten, vice president of the Norwegian Parliament and chair of the GAVI Alliance Board, writes in the Huffington Post's "Impact" blog, adding, "Over the next six months, more than half a million children in the country will be protected from diphtheria, pertussis, tetanus, hepatitis B (hepB), and Haemophilus influenzae type b.
RESILIENT was a single arm, open label, phase II/III study to test if label agnostic therapy regimens guided by Encyclopedic Tumor Analysis can offer meaningful clinical benefit for patients with relapsed refractory metastatic malignancies.
› Verified 8 days ago
| NPI Number | 1730364324 |
| Organization Name | BLOOMINGDALE CARE OPERATING CO LLC |
| Address | 42235 County Road 390, Bloomingdale, MI 49026 |
| Phone Number | 269-521-3383 |
News Archive
Uganda "has overcome a violent past, but hope is daily threatened by a force more deadly than any warlord or civil unrest": the mosquito, Ugandan Health Minister Christine Ondoa writes in a GlobalPost opinion piece. According to the WHO, "Uganda has the highest incidence of malaria in the world," and the disease is endemic in more than 95 percent of the country, she notes.
A new study from University of Manchester researchers, published in ACS Neuro, shows a high possibility of treating stroke patients using very small cell sacs called liposomes to bypass the blood brain barrier and carry lifesaving drugs to the brain to prevent damage following a stroke.
Inspire Pharmaceuticals, Inc. announced today that it has been communicating with the U.S. Food and Drug Administration (FDA) and is increasing its production of AzaSite® (azithromycin ophthalmic solution) 1% in response to the manufacturing supply shortage of erythromycin ophthalmic ointment (0.5%).
"For the first time, with support from the GAVI Alliance, a pentavalent vaccine was introduced in Myanmar this week that will defend children against five potentially fatal diseases," Dagfinn Hoybraten, vice president of the Norwegian Parliament and chair of the GAVI Alliance Board, writes in the Huffington Post's "Impact" blog, adding, "Over the next six months, more than half a million children in the country will be protected from diphtheria, pertussis, tetanus, hepatitis B (hepB), and Haemophilus influenzae type b.
RESILIENT was a single arm, open label, phase II/III study to test if label agnostic therapy regimens guided by Encyclopedic Tumor Analysis can offer meaningful clinical benefit for patients with relapsed refractory metastatic malignancies.
› Verified 8 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Uganda "has overcome a violent past, but hope is daily threatened by a force more deadly than any warlord or civil unrest": the mosquito, Ugandan Health Minister Christine Ondoa writes in a GlobalPost opinion piece. According to the WHO, "Uganda has the highest incidence of malaria in the world," and the disease is endemic in more than 95 percent of the country, she notes.
A new study from University of Manchester researchers, published in ACS Neuro, shows a high possibility of treating stroke patients using very small cell sacs called liposomes to bypass the blood brain barrier and carry lifesaving drugs to the brain to prevent damage following a stroke.
Inspire Pharmaceuticals, Inc. announced today that it has been communicating with the U.S. Food and Drug Administration (FDA) and is increasing its production of AzaSite® (azithromycin ophthalmic solution) 1% in response to the manufacturing supply shortage of erythromycin ophthalmic ointment (0.5%).
"For the first time, with support from the GAVI Alliance, a pentavalent vaccine was introduced in Myanmar this week that will defend children against five potentially fatal diseases," Dagfinn Hoybraten, vice president of the Norwegian Parliament and chair of the GAVI Alliance Board, writes in the Huffington Post's "Impact" blog, adding, "Over the next six months, more than half a million children in the country will be protected from diphtheria, pertussis, tetanus, hepatitis B (hepB), and Haemophilus influenzae type b.
RESILIENT was a single arm, open label, phase II/III study to test if label agnostic therapy regimens guided by Encyclopedic Tumor Analysis can offer meaningful clinical benefit for patients with relapsed refractory metastatic malignancies.
› Verified 8 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $9750 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 22.84 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 12.99 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 50.72 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 4.22 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 4.47 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 97.21 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 23.81 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 95.73 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 34.28 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 19.76 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 5.69 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.51 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 61.93 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 84.5 | 82.93 |
News Archive
Uganda "has overcome a violent past, but hope is daily threatened by a force more deadly than any warlord or civil unrest": the mosquito, Ugandan Health Minister Christine Ondoa writes in a GlobalPost opinion piece. According to the WHO, "Uganda has the highest incidence of malaria in the world," and the disease is endemic in more than 95 percent of the country, she notes.
A new study from University of Manchester researchers, published in ACS Neuro, shows a high possibility of treating stroke patients using very small cell sacs called liposomes to bypass the blood brain barrier and carry lifesaving drugs to the brain to prevent damage following a stroke.
Inspire Pharmaceuticals, Inc. announced today that it has been communicating with the U.S. Food and Drug Administration (FDA) and is increasing its production of AzaSite® (azithromycin ophthalmic solution) 1% in response to the manufacturing supply shortage of erythromycin ophthalmic ointment (0.5%).
"For the first time, with support from the GAVI Alliance, a pentavalent vaccine was introduced in Myanmar this week that will defend children against five potentially fatal diseases," Dagfinn Hoybraten, vice president of the Norwegian Parliament and chair of the GAVI Alliance Board, writes in the Huffington Post's "Impact" blog, adding, "Over the next six months, more than half a million children in the country will be protected from diphtheria, pertussis, tetanus, hepatitis B (hepB), and Haemophilus influenzae type b.
RESILIENT was a single arm, open label, phase II/III study to test if label agnostic therapy regimens guided by Encyclopedic Tumor Analysis can offer meaningful clinical benefit for patients with relapsed refractory metastatic malignancies.
› Verified 8 days ago
Meadow Woods Nursing And Rehab Center Location: 42235 County Road 390, Bloomingdale, Michigan 49026 Phone: (269) 521-3383 |